Abstract

ObjectivesIn the open-label Phase III SOLO3 trial (NCT02282020), olaparib treatment improved objective response rate (primary endpoint) and progression-free survival, versus single-agent non-platinum chemotherapy treatment of physician’s choice (TPC), in patients...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: secondary efficacy results from the phase II LIGHT study
Karen Cadoo ... Carol Aghajanian
Gynecologic oncology | VOL. 162
Karen Cadoo, et. al.Karen Cadoo ... Carol Aghajanian
01 Aug 2021
Abstract PD4-03: OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
Mark Robson ... Allison Allen
American Journal of Cancer | VOL. 80
Mark Robson, et. al.Mark Robson ... Allison Allen
14 Feb 2020
Final overall survival results from SOLO3: Phase III trial assessing olaparib monotherapy versus non-platinum chemotherapy in heavily pretreated patients with germline BRCA1 - and/or BRCA2-mutated platinum-sensitive relapsed ovarian cancer (026)
Richard Penson ... Giovanni Scambia
Gynecologic oncology | VOL. 166
Richard Penson, et. al.Richard Penson ... Giovanni Scambia
01 Aug 2022
Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study.
Shanu Modi ...
Journal of Clinical Oncology | VOL. 40
Shanu Modi, et. al.Shanu Modi ...
10 Jun 2022
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Robotic staging for early ovarian cancer in 10 steps
Aniello Foresta ... Valerio Gallotta
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Aniello Foresta, et. al.Aniello Foresta ... Valerio Gallotta
01 Jul 2024
Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes
Arwa Mohammad ... William Cliby
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Arwa Mohammad, et. al.Arwa Mohammad ... William Cliby
01 Jul 2024
Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer
Filip Fruhauf ... Daniela Fischerova
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 34
Filip Fruhauf, et. al.Filip Fruhauf ... Daniela Fischerova
01 Jul 2024
Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment
Stefano Restaino ... Giuseppe Vizzielli
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Stefano Restaino, et. al.Stefano Restaino ... Giuseppe Vizzielli
01 Jul 2024
View more papers